Lapatinib plus capecitabine in metastatic human epidermal growth factor receptor 2-positive breast cancer patients that received prior therapy with trastuzumab and pertuzumab: Better option than T-DM1? | AVESİS

Hacettepe Üniversitesi Akademik Veri Yönetim Sistemi

Lapatinib plus capecitabine in metastatic human epidermal growth factor receptor 2-positive breast cancer patients that received prior therapy with trastuzumab and pertuzumab: Better option than T-DM1?

Atıf İçin Kopyala

JOURNAL OF BUON, cilt.22, ss.281-282, 2017 (SCI İndekslerine Giren Dergi)

Cilt numarası: 22 Konu: 1
Basım Tarihi: 2017
Dergi Adı: JOURNAL OF BUON
Sayfa Sayıları: ss.281-282